Skip to main content

Advertisement

Log in

DNA Ligase IV Deficiency Identified by Chance Following Vaccine-Derived Rubella Virus Infection

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Abbreviations

ALT:

Alanine aminotransferase

AST:

Aspartate aminotransferase

BMT :

Bone marrow transplantation

CDR3:

Complementarity-determining region 3

GVHD:

Graft-versus-host disease

HSCT:

Hematopoietic stem cell transplantation

iVDRV:

Immunodeficiency-related vaccine-derived rubella virus

PID:

Primary immunodeficiency disease

KRECs:

Kappa-deleting recombination excision circles

PBMCs:

Peripheral blood mononuclear cells

SCID:

Severe combined immunodeficiency

TRECs:

T cell receptor excision circles

VDRV:

Vaccine-derived rubella virus

VZV:

Varicella-zoster virus

References

  1. Tingle AJ, Chantler JK, Pot KH, Paty DW, Ford DK. Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia. J Infect Dis United States. 1985;152:606–12.

    Article  CAS  Google Scholar 

  2. Chantler JK, Ford DK, Tingle AJ. Rubella-associated arthritis: rescue of rubella virus from peripheral blood lymphocytes two years postvaccination. Infect Immun. 1981;32:1274–80.

    Article  CAS  Google Scholar 

  3. Tingle AJ, Mitchell LA, Grace M, Middleton P, Mathias R, MacWilliam L, et al. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Lancet. 1997;349:1277–81.

  4. Buchbinder D, Hauck F, Albert MH, Rack A, Bakhtiar S, Shcherbina A, et al. Rubella virus-associated cutaneous granulomatous disease: a unique complication in immune-deficient patients, not limited to DNA repair disorders. J Clin Immunol. 2019;39:81–9.

  5. Boone ATS, Chinn IK, Alaez-Versón C, Yamazaki-Nakashimada MA, Carrillo-Sánchez K, de la LH G-CM, et al. Failing to make ends meet: the broad clinical spectrum of DNA ligase IV deficiency. Case series and review of the literature. Front Pediatr. 2019;6:1–13.

    Google Scholar 

  6. Leclerc-Mercier S, Moshous D, Neven B, Mahlaoui N, Martin L, Pellier I, et al. Cutaneous granulomas with primary immunodeficiency in children: a report of 17 new patients and a review of the literature. J Eur Acad Dermatol Venereol. 2019;33:1412–20.

  7. Perelygina L, Plotkin S, Russo P, Hautala T, Bonilla F, Ochs HD, et al. Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies. J Allergy Clin Immunol. 2016;138:1436–1439.e11.

    Article  CAS  Google Scholar 

  8. Perelygina L, Chen MH, Suppiah S, Adebayo A, Abernathy E, Dorsey M, et al. Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies. PLoS Pathog. 2019;15:e1008080.

  9. O’Driscoll M, Cerosaletti KM, Girard PM, Dai Y, Stumm M, Kysela B, et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell. 2001;8:1175–85.

    Article  Google Scholar 

  10. Chistiakov DA, Voronova NV, Chistiakov AP. Ligase IV syndrome. Eur J Med Genet. 2009;52:373–8.

    Article  Google Scholar 

  11. Slack J, Albert MH, Balashov D, Belohradsky BH, Bertaina A, Bleesing J, et al. Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders. J Allergy Clin Immunol. 2018;141:322–8 e10.

  12. Tamura S, Higuchi K, Tamaki M, Inoue C, Awazawa R, Mitsuki N, et al. Novel compound heterozygous DNA ligase IV mutations in an adolescent with a slowly-progressing radiosensitive-severe combined immunodeficiency. Clin Immunol. 2015;160:255–60.

Download references

Acknowledgments

We thank Drs. Harutaka Katano and Hideki Hasegawa at the Department of Pathology, National Institute of Infectious Diseases, for performing the immunohistochemical staining of rubella antigen, and Drs. Tzu-Wen Yeh and Kay Tanita for their technical assistance. We also thank Enago (www.enago.jp) for the English language review.

Funding

This work was supported by the MEXT/JSPS KAKENHI (Grant Number: JP17K10099) to HK.

Author information

Authors and Affiliations

Authors

Contributions

KM contributed to data collection and writing of the manuscript. AH and TK performed the genetic analysis. YM performed the virological study. MH contributed to the pathological diagnosis. KM, AH, AN, MS, CN, KW, NM, MT, and KI treated the patient. SN and TM supervised the study. HK conceptualized the study and extensively edited and revised the manuscript.

Corresponding author

Correspondence to Hirokazu Kanegane.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

ESM 1

(DOCX 1533 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matsumoto, K., Hoshino, A., Nishimura, A. et al. DNA Ligase IV Deficiency Identified by Chance Following Vaccine-Derived Rubella Virus Infection. J Clin Immunol 40, 1187–1190 (2020). https://doi.org/10.1007/s10875-020-00831-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-020-00831-5

Navigation